Browse by Audience
Skip to content
Papers of the Week
An overview on disease modifying and symptomatic drug treatments for multiple sclerosis.
Authors
Dalla Costa G, Leocani L, Rodegher M, Chiveri L, Gradassi A, Comi GAbstract
Multiple sclerosis (MS) is an inflammatory and degenerative autoimmune condition, resulting frequently in a disabling condition. Significant improvements of long-term prognosis have been recently achieved with an early and more aggressive use of disease modifying therapies (DMTs). Addressing the complexity of managing its progressive forms remains a significant challenge.